Life Science Company News

Reset
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Crossject and the U.S. Department of Defense Relaunch Joint Research on Needle-free Autoinjectors, Extending Their Cooperative Research and Development Agreement

Read more ››
By: GlobeNewswire - 09 Dec 2024
Related companies:  Crossject

KFSHRC Leads Innovation in Cancer Radiopharmaceuticals

Read more ››
By: GlobeNewswire - 09 Dec 2024
Related companies:  King Faisal Specialist Hospital & Research Centre

AAVantgarde presents safety data of the first two subjects dosed in the LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B at FLORetina 2024

Read more ››
By: GlobeNewswire - 09 Dec 2024
Related companies:  AAVantgarde Bio s.r.l.

Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders

Read more ››
By: GlobeNewswire - 09 Dec 2024
Related companies:  Citryll BV

DARZALEX® (daratumumab) SC-based regimens improve MRD negativity and progression-free survival in newly diagnosed multiple myeloma, and overall survival in AL amyloidosis

Read more ››
By: GlobeNewswire - 09 Dec 2024

Nikon and eLabNext collaborate to integrate the NIS-Elements imaging platform with eLabNext’s Digital Lab Platform in the US

Read more ››
By: GlobeNewswire - 09 Dec 2024
Related companies:  eLabNext | eLabNext

Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers

Read more ››
By: GlobeNewswire - 09 Dec 2024
Related companies:  Medigene AG

MGI Tech's Innovative Sequencing Technology Drives Mangrove Conservation Efforts in Thailand

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  MGI Tech Co., Ltd.

Philips and Singapore General Hospital to advance medical imaging capabilities in Asia Pacific with first-of-its-kind MRI training collaboration

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  Philips International B.V.

Dr. James G. Fujimoto of U.S. Awarded 45th Honda Prize for His Team's Development of Optical Coherence Tomography (OCT): Real-time Tissue Imaging Technology

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-cell Non-Hodgkin Lymphoma at the 2024 ASH Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

IDEAYA Biosciences Announces Development Candidate Nomination of IDE892, a Potential Best-in-Class MTA-cooperative PRMT5 Inhibitor

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  IDEAYA Biosciences, Inc.

Vincent Aurentz Joins Forward Therapeutics' Board of Directors

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  Forward Therapeutics, Inc.

Norwegian healthcare region expands enterprise imaging contract with Sectra--digitizes pathology diagnostics to improve cancer care

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  Sectra AB

Immunovia announces positive outcome and strong accuracy in the clinical validation of its next-generation test for pancreatic cancer

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  Immunovia AB

Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

Zelixir's New Factory to Revolutionize Natural Fragrance Production with ‘AI+Synthetic Biology’

Read more ››
By: GlobeNewswire - 09 Dec 2024

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function

Read more ››
By: GlobeNewswire - 09 Dec 2024
Related companies:  Vivoryon Therapeutics N.V.

Taiwan's Products for Modern Households Focus on Customization, Health, and Wellbeing

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

2024 ASH Oral Presentation----Abbisko presents promising preliminary phase 2 study results of pimicotinib in the treatment of Chronic Graft-versus-Host Disease (cGvHD) at the 66th ASH Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »